Mr. Ran Nussbaum: Mr. Nussbaum is a managing partner and the co-founder of The Pontifax Group, who has established three funds with over $220M under management and over 40 portfolio companies. Over the past ten years, Mr. Nussbaum has been managing the group’s activity alongside Mr. Tomer Kariv. He also served as CEO of Biomedix and Spearhead Ltd as well as Ocon Medical chairman of the board. Mr. Nussbaum’s real life experience in the life sciences arena, coupled with a 10-year experience in the business intelligence field, creates a unique blend of skills, enabling him to support companies from inception to commercialization. His work revolves around constant and active involvement in companies, providing them with strategic and business development oversight. Mr. Nussbaum serves as a board member of many of the group’s portfolio companies, including Kite Pharma (public company) c-CAM, Insuline (public company), Eloxx, Bioblast (public company), TheraCoat, and Ocon Medical.